Little House Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-40,196
Closed -$1.16M 120
2024
Q3
$1.16M Buy
40,196
+5,593
+16% +$163K 0.33% 71
2024
Q2
$968K Sell
34,603
-247
-0.7% -$6.8K 0.3% 71
2024
Q1
$967K Buy
34,850
+2,976
+9% +$82.6K 0.32% 78
2023
Q4
$918K Sell
31,874
-10,588
-25% -$320K 0.33% 77
2023
Q3
$1.41M Buy
42,462
+29,783
+235% +$1.05M 0.58% 47
2023
Q2
$465K Buy
12,679
+49
+0.4% +$1.91K 0.2% 93
2023
Q1
$515K Buy
12,630
+346
+3% +$14.9K 0.24% 88
2022
Q4
$629K Sell
12,284
-46
-0.4% -$2.21K 0.31% 74
2022
Q3
$540K Buy
12,330
+18
+0.1% +$875 0.29% 81
2022
Q2
$645K Sell
12,312
-347
-3% -$17.7K 0.35% 76
2022
Q1
$655K Sell
12,659
-603
-5% -$31.3K 0.34% 80
2021
Q4
$783K Buy
13,262
+509
+4% +$25.2K 0.41% 68
2021
Q3
$549K Sell
12,753
-2,052
-14% -$90.9K 0.32% 88
2021
Q2
$580K Buy
+14,805
New +$576K 0.31% 92
2021
Q1
Sell
-38,777
Closed -$1.43M 143
2020
Q4
$1.43M Sell
38,777
-3,349
-8% -$123K 1.05% 36
2020
Q3
$1.47M Buy
42,126
+716
+2% +$25.1K 1.22% 33
2020
Q2
$1.28M Sell
41,410
-3,576
-8% -$121K 1.18% 35
2020
Q1
$1.39M Sell
44,986
-1,035
-2% -$35.3K 1.52% 25
2019
Q4
$1.71M Sell
46,021
-15,055
-25% -$536K 1.48% 29
2019
Q3
$2.08M Buy
61,076
+282
+0.5% +$10.3K 1.58% 17
2019
Q2
$2.48K Buy
60,794
+3,058
+5% +$121K 1.66% 16
2019
Q1
$2.33M Buy
57,736
+588
+1% +$23.5K 1.74% 15
2018
Q4
$2.37M Buy
+57,148
New +$2.37M 2.29% 10

Other funds holding PFE

Little House Capital's PFE Position: Q4 2024 in Review

Little House Capital sold out of Pfizer (PFE) in Q4 2024, closing a stake of 40,196 shares — an estimated $1.16M sold.

Little House Capital first reported a position in PFE in Q4 2018 and held it in 23 quarters. The position peaked at $2.37M in Q4 2018. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Little House Capital reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Little House Capital sold 40,196 Pfizer shares in Q4 2024, an estimated $1.16M.
  • Little House Capital first reported a position in Pfizer in Q4 2018 and held it in 23 quarters.
  • Little House Capital's Pfizer position peaked at $2.37M in Q4 2018.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Little House Capital's 13F filing for Q4 2024, filed 30 Jan 2025.